Split-course radiotherapy: where do we stand?
Dubben HH, Krüll A, Beck-Bornholdt HP.
Strahlenther Onkol. 2001 May;177(5):227-39. doi: 10.1007/pl00002402.
Updated Outcomes of Split Course Radiotherapy in Elderly or Infirm Patients With Advanced Cancers of the Head and Neck.
Domb C, Smile TD, Reddy C, Woody NM, Campbell SR, Canavan JF, Joshi NP, Greskovich JF, Chute DJ, Burkey BB, Ku LA, Lamarre E, Lorenz RR, Prendes B, Scharpf J, Schwartzman L, Geiger JL, Koyfman SA, Fleming CW.
Anticancer Res. 2021 Oct;41(10):4995-5000. doi: 10.21873/anticanres.15313.
Feasibility of split-course stereotactic ablative radiotherapy for oligometastases.
Paik EK, Kim MS, Seo YS, Jang WI, Kang JK, Cho CK, Yoo HJ.
Jpn J Clin Oncol. 2018 Jun 1;48(6):548-554. doi: 10.1093/jjco/hyy062.
Split-course hypofractionated radiotherapy for aged and frail patients with head and neck cancers. A retrospective study of 75 cases.
Benhmida S, Sun R, Gherga E, Hammoud Y, Rouvier J, Mauvais O, Bockel S, Louvrier A, Lebbad A, Bontemps P, Ortholan C, Bourhis J, Lestrade L, Sun XS.
Cancer Radiother. 2020 Dec;24(8):812-819. doi: 10.1016/j.canrad.2020.03.013. Epub 2020 Nov 2.
Split-course radiotherapy of cancer.
Holsti LR.
Acta Radiol Ther Phys Biol. 1967 Aug;6(4):313-22. doi: 10.3109/02841856709138592.
An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer.
Adelstein DJ, Li Y, Adams GL, Wagner H Jr, Kish JA, Ensley JF, Schuller DE, Forastiere AA.
J Clin Oncol. 2003 Jan 1;21(1):92-8. doi: 10.1200/JCO.2003.01.008.
Split-Course Accelerated Hypofractionated Radiotherapy (SCAHRT): A Safe and Effective Option for Head and Neck Cancer in the Elderly or Infirm.
Bledsoe TJ, Noble AR, Reddy CA, Burkey BB, Greskovich JF, Nwizu T, Adelstein DJ, Saxton JP, Koyfman SA.
Anticancer Res. 2016 Mar;36(3):933-9.
Split-course radiotherapy for urinary bladder cancer.
Salminen E.
Radiother Oncol. 1989 Aug;15(4):327-31. doi: 10.1016/0167-8140(89)90078-9.
Combining chemotherapy and tislelizumab with preoperative split-course hypofraction radiotherapy for locally advanced rectal cancer: study protocol of a prospective, single-arm, phase II trial.
Zheng R, Wang BS, Li Z, Chi P, Xu B.
BMJ Open. 2023 Mar 16;13(3):e066976. doi: 10.1136/bmjopen-2022-066976.
Split-course, high-dose palliative pelvic radiotherapy for locally progressive hormone-refractory prostate cancer.
Gogna NK, Baxi S, Hickey B, Baumann K, Burmeister E, Holt T.
Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):e205-11. doi: 10.1016/j.ijrobp.2011.12.028. Epub 2012 Feb 16.
